Hypera S.A.
OTC: HYPMY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Breno Toledo Pires de Oliveira
- Employees
- 10,481
- Headquarters
- São Paulo, Brazil
- IPO year
- 2010
- Market cap
- $2.9B
- Website
- https://www.hyperapharma.com.br
Loading HYPMY…
Loading profile data…Frequently asked questions about HYPMY
What does Hypera S.A. (HYPMY) do?
Hypera S.A. is a prominent pharmaceutical enterprise primarily operating within Brazil. The company maintains a diverse product portfolio that includes a vast array of prescription medications, marketed under numerous brand names such as Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C...
Where does HYPMY trade?
Hypera S.A. (HYPMY) trades on the Other OTC.
What sector is HYPMY in?
Hypera S.A. (HYPMY) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Hypera S.A.?
Breno Toledo Pires de Oliveira is the chief executive officer of Hypera S.A. (HYPMY).
Where is Hypera S.A. headquartered?
Hypera S.A. is headquartered in Brazil.
Does HYPMY pay a dividend?
Yes — Hypera S.A. (HYPMY) paid a trailing twelve-month dividend of USD 0.26 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did HYPMY go public?
Hypera S.A. (HYPMY) completed its initial public offering in 2010.
Is HYPMY an ADR?
Yes — HYPMY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Hypera S.A. reporting and dividends follow the underlying issuer.